CAPTRUST FINANCIAL ADVISORS - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 78 filers reported holding CARDIFF ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q2 2022$1,0000.0%4090.0%0.00%
Q1 2022$1,000
-50.0%
4090.0%0.00%
Q4 2021$2,000
-66.7%
409
-52.4%
0.00%
Q3 2021$6,0000.0%8600.0%0.00%
Q2 2021$6,000
-25.0%
8600.0%0.00%
Q1 2021$8,000
-20.0%
860
+53.6%
0.00%
Q4 2020$10,000
+11.1%
560
-11.8%
0.00%
Q3 2020$9,000
+200.0%
6350.0%0.00%
Q2 2020$3,0006350.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$299,0000.32%
Artal Group S.A. 750,000$1,860,0000.08%
Eventide Asset Management 1,467,922$3,640,0000.06%
Atom Investors LP 33,798$84,0000.04%
XTX Topco Ltd 25,154$62,0000.03%
ELKHORN PARTNERS LIMITED PARTNERSHIP 19,000$47,0000.02%
Engineers Gate Manager LP 245,567$609,0000.02%
GSA CAPITAL PARTNERS LLP 63,749$158,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 168,902$419,0000.01%
Walleye Capital LLC 123,305$306,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders